| Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19) AM Baig, EC Sanders Journal of medical virology 92 (10), 1845-1857, 2020 | 147 | 2020 |
| Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV‐2 infection S Sheikh‐Mohamed, EC Sanders, JL Gommerman, MC Tal Immunological Reviews 309 (1), 75-85, 2022 | 38 | 2022 |
| Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection GR Nahass, RE Salomon-Shulman, G Blacker, K Haider, R Brotherton, ... Medrxiv, 2021.08. 22.21262168, 2021 | 20 | 2021 |
| Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19 AM Baig, EC Sanders ACS Chemical Neuroscience 11 (12), 1701-1703, 2020 | 7 | 2020 |
| Secretoglobin family 1D member 2 (SCGB1D2) protein inhibits growth of Borrelia burgdorferi and affects susceptibility to Lyme disease S Strausz, G Blacker, S Galloway, P Hansen, SE Jones, E Sanders, ... bioRxiv, 2022.05. 27.493784, 2022 | 2 | 2022 |
| Characterization of pathological IgE-mediated mast cell activation in Lyme disease SD Galloway, M Shoham, B Lee, LB Torrez-Dulgeroff, I Irnov, A Lin, ... The Journal of Immunology 208 (1_Supplement), 161.12-161.12, 2022 | | 2022 |
| Low and transient salivary neutralizing antibodies after COVID vaccination G Nahass, R Salomon-Shulman, S Sheikh-Mohamed, G Blacker, ... The Journal of Immunology 208 (1_Supplement), 114.24-114.24, 2022 | | 2022 |
| Novel Association of Lyme disease, Age, and Atopic Dermatitis BT Lee, SD Galloway, S Strausz, M Shoham, P Hansen, LBT Dulgeroff, ... bioRxiv, 2022.01. 27.476641, 2022 | | 2022 |
